CNTA - Bathi sadurunge bunga, pajak, lan amortisasi Centessa Pharmaceuticals plc

Logo grafis Centessa (CNTA)

Centessa Pharmaceuticals (CNTA) is facing a liquidity shortage and a gradual depletion of resources due to R&D expenditures. The trend in gross operating profit before depreciation reflects the current situation, where the value is maintained at 0.00. This is occurring against the backdrop of developing innovative therapies for sleep disorders and management's efforts to attract investment into autonomous research centers.

CNTA Centessa Corp: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 04.07.2026

Ringkesan rincian data analitis Centessa Pharmaceuticals PLC (CNTA)

Analisis kabeh metrik perusahaan:Centessa Pharmaceuticals
Produk asil prodhuksi Centessa Pharmaceuticals plc

This indicator measures net cash flow from operating activities before non-cash charges, allowing for the immediate identification of operational flow disruptions. By analyzing the recorded EBITDA level, an investor assesses the real liquidity of Centessa Pharmaceuticals (CNTA), which is critical given the absence of stable revenue and the company's reliance on external financing amid risky clinical trials.

Karo sapa Centessa Pharmaceuticals saingan

JAZZ: Bathi operasional sadurunge amortisasi|Cytokinetics Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PTC Therapeutics Corp|SRRK (Scholar Rock, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|Dyne Corp - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Edgewise Therapeutics|RAPP: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alumis Pharma (ALMS)|ZVRA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Contineum Pharma CTNM|Larimar Corp - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CAPR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Entrada Therapeutics|PTHS: Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi MediciNova, Inc. MNOV|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Serina Pharma|Bathi sadurunge bunga, pajak, lan amortisasi BioXcel BTAI|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ProMIS Neurosciences Inc. (PMN)|Bathi operasional EBITDA Apimeds Pharmaceuticals, Inc. (APUS)|Bathi operasional EBITDA AEON (AEON Biopharma, Inc.)|NLS Pharmaceutics AG - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|BNOX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|HUGE (FSD Pharma Inc.) - Bathi operasional sadurunge amortisasi|RETA (Reata) - Bathi operasional sadurunge ngurangi amortisasi